Prognostic value of Ki-67 for recurrence and progression of superficial bladder cancer

被引:40
作者
Asakura, T
Takano, Y
Iki, M
Suwa, Y
Noguchi, S
Kubota, Y
Masuda, M
机构
[1] YOKOHAMA CITY UNIV,SCH MED,DEPT UROL,KANAZAWA KU,YOKOHAMA,KANAGAWA 236,JAPAN
[2] KITASATO UNIV,SCH MED,DEPT PATHOL,SAGAMIHARA,KANAGAWA 228,JAPAN
[3] FUKUI MED SCH,DEPT ENVIRONM HLTH,YOSHIDA,FUKUI,JAPAN
关键词
bladder; bladder neoplasms; carcinoma; transitional cell; antigen;
D O I
10.1016/S0022-5347(01)64485-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We retrospectively reviewed 104 cases of superficial bladder cancer to ascertain whether the Ki-67 labeling index predicts recurrence and progression. Materials and Methods: Archival specimens from superficial bladder cancer cases were immunostained with Ki-67. Results: The recurrence rate was significantly higher in cases with a Ki-67 labeling index of 5.35 or greater than in those with a value less than 5.35 (p < 0.001), The recurrence rate at 2 years was 70% in cases with a Ki-67 labeling index of 5.35 or greater and 22% in those with an index less than 5.35 (p < 0.001). Using multivariate analysis the index predicted recurrence of bladder cancer (p < 0.005). Median Ki-67 labeling index in cases with progression was significantly higher than in those without progression (p < 0.01), Conclusions: The Ki-67 labeling index is an independent predictive factor for recurrence of superficial bladder cancer.
引用
收藏
页码:385 / 388
页数:4
相关论文
共 26 条
[1]  
Allard P, 1995, CLIN CANCER RES, V1, P1195
[2]   Superficial bladder cancer: Study of the proliferative nuclear fraction as a prognostic factor [J].
BlascoOlaetxea, E ;
Belloso, L ;
GarciaTamayo, J .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (03) :444-446
[3]   PROLIFERATION IN HUMAN BLADDER-CARCINOMA MEASURED BY KI-67 ANTIBODY LABELING - ITS POTENTIAL CLINICAL IMPORTANCE [J].
BUSH, C ;
PRICE, P ;
NORTON, J ;
PARKINS, CS ;
BAILEY, MJ ;
BOYD, J ;
JONES, CR ;
AHERN, RP ;
HORWICH, A .
BRITISH JOURNAL OF CANCER, 1991, 64 (02) :357-360
[4]   PROGNOSTIC FACTORS IN SUPERFICIAL BLADDER-TUMORS - A STUDY OF THE EUROPEAN ORGANIZATION FOR RESEARCH ON TREATMENT OF CANCER - GENITOURINARY TRACT CANCER COOPERATIVE GROUP [J].
DALESIO, O ;
SCHULMAN, CC ;
SYLVESTER, R ;
DEPAUW, M ;
ROBINSON, M ;
DENIS, L ;
SMITH, P ;
VIGGIANO, G ;
SOLOWAY, MS .
JOURNAL OF UROLOGY, 1983, 129 (04) :730-733
[5]   MONOCLONAL-ANTIBODY KI-67 IN THE STUDY OF THE PROLIFERATIVE ACTIVITY OF BLADDER-CARCINOMA [J].
FONTANA, D ;
BELLINA, M ;
GUBETTA, L ;
FASOLIS, G ;
ROLLE, L ;
SCOFFONE, C ;
PORPIGLIA, F ;
COLOMBO, M ;
TARABUZZI, R ;
LEONARDO, E .
JOURNAL OF UROLOGY, 1992, 148 (04) :1149-1151
[6]   PRODUCTION OF A MOUSE MONOCLONAL-ANTIBODY REACTIVE WITH A HUMAN NUCLEAR ANTIGEN ASSOCIATED WITH CELL-PROLIFERATION [J].
GERDES, J ;
SCHWAB, U ;
LEMKE, H ;
STEIN, H .
INTERNATIONAL JOURNAL OF CANCER, 1983, 31 (01) :13-20
[7]   SUPERFICIAL BLADDER-CANCER - PROGRESSION AND RECURRENCE [J].
HENEY, NM ;
AHMED, S ;
FLANAGAN, MJ ;
FRABLE, W ;
CORDER, MP ;
HAFERMANN, MD ;
HAWKINS, IR .
JOURNAL OF UROLOGY, 1983, 130 (06) :1083-1086
[8]  
HERMANEK P, 1992, TNM CLASSIFICATION M, P154
[9]   AN OVERVIEW OF INTRAVESICAL THERAPY FOR SUPERFICIAL BLADDER-TUMORS [J].
HERR, HW ;
LAUDONE, VP ;
WHITMORE, WF .
JOURNAL OF UROLOGY, 1987, 138 (06) :1363-1368
[10]   INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY FOR SUPERFICIAL BLADDER-CANCER - EFFECT OF BACILLUS CALMETTE-GUERIN VIABILITY ON TREATMENT RESULTS [J].
KELLEY, DR ;
RATLIFF, TL ;
CATALONA, WJ ;
SHAPIRO, A ;
LAGE, JM ;
BAUER, WC ;
HAAFF, EO ;
DRESNER, SM .
JOURNAL OF UROLOGY, 1985, 134 (01) :48-53